PursueCare’s Nick Mercadante (CEO) and Steven Powell, MD (Chief Medical Officer) will be speaking about using emerging telehealth technologies to treat opioid use disorders as faculty at the National Conference on Addiction Disorders (NCAD East). The session, which takes place at 10:15am on Saturday August 17th, 2019 in Baltimore, MD, is entitled Telemedicine MAT: Clinical and Operational Considerations for Direct-to-Consumer and Collaborative Models.
The speaking engagement will feature discussion of key considerations, challenges, and proven methods for success in serving the ever-growing demand for effective intervention care, transition care, and improved access to Medication-Assisted Treatment (“MAT”) using established and emerging telehealth models. Mr. Mercadante and Dr. Powell are expected to highlight trends and developments in state and federal law governing the provision of telemedicine for MAT, as well as emerging models for care. Attendees will be presented with research and discussion about novel solutions to: answer issues with access to MAT; improve collaborative care and transitions of care; and destigmatize patient-centered care for improved engagement and outcomes.
NCAD East takes place from August 15-18 at the Baltimore Marriott Waterfront. It is the premier continuing education conference for addiction, behavioral, and mental health professionals. The conference draws clinicians and executives alike, working to improve and refine patient care as well as develop sustainable and successful treatment organizations. Particular focus on new solutions to address the nationwide opioid epidemic is anticipated.
PursueCare (https://www.pursuecare.com) is a technology-enabled health services startup aiming to help solve the nation’s growing opioid epidemic. The company has launched a first-of-its-kind telehealth opioid addiction treatment platform available to patients through an iOS/Android mobile app, tablet, or computer. Patients can use PursueCare’s platform to access Medication-Assisted Treatment like Suboxone from qualified physicians, addiction counseling, and mail-order pharmacy services. PursueCare is actively bringing together providers into a network of programmatic evidence-based care. The platform offers a way to provide on-demand, interventive, and transitional care to patients coming from hospital inpatient and emergency department, primary care, and rural health clinic settings. It is also directly accessible by patients, or can be offered by insurance plans and employers as a means for lower cost and more personalized treatment at home.
PursueCare has formed nationwide low-cost lab and toxicology screening partnerships, and anticipates also bringing a number of machine-learning recovery self-help and peer-support resources to patients directly through its app. PursueCare is forming partnerships nationwide with treatment providers, insurance payors, hospitals, primary care, and rural health clinics in an effort to bring greater access to effective and evidence-based treatment to Kentucky, West Virginia, and other states that have been heavily impacted by opioids.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.